Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats

Circulation

Volumn 93, Issue 10, 1996, Pages 1905-1912

  Norton, Gavin R ^a,b   Candy, Geoff ^a   Woodiwiss, Angela J ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

aminoguanidine; cardiomyopathy; diabetes mellitus; diastole; myocardium

Indexed keywords

AMINOGUANIDINE; CAPTOPRIL; COLLAGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG SCREENING; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE COMPLIANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

EID: 0029946123     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.10.1905     Document Type: Article

References (28)

1. Lo SS, Leslie DG, Sutton MJ. Effect of type I diabetes on left ventricular size and function: a prospective Doppler echo study of identical twins. Circulation. 1991;84(suppl II):II-369. Abstract.
2. Haider B, Yeh CK, Thomas G, Oldewurtel HA, Lyons MM, Regan TJ. Influence of diabetes on the myocardium and coronary arteries of rhesus monkey fed an atherogenic diet. Circ Res. 1981;49: 1278-1288.
3. Regan TJ, Wu CF, Yeh CK, Oldewurtel HA, Haider B. Myocardial composition and function in diabetes. Circ Res. 1981;49:1268-1277.
4. Regan TJ, Ettinger PO, Khan MI, Jesrani MV, Lyons MM, Oldewurtel HA, Weber M. Altered myocardial function and metabolism in chronic diabetes mellitus without ischemia in dogs. Circ Res. 1974;35:222-237.
5. Schaffer SW, Mozzaffari MS, Artman M, Wilson GL. Basis for myocardial mechanical defects associated with non-insulin-dependent diabetes. Am J Physiol. 1989;256:E25-E30.
6. Khaidar A, Marx M, Lubec B, Lubec G. L-Arginine reduces heart collagen accumulation in the diabetic db/db mouse. Circulation. 1994;90:479-483.
7. Kita Y, Shimizu M, Sugihara N, Shimizu K, Yoshio H, Shibayama S, Takeda R. Correlation between histopathological changes and mechanical dysfunction in diabetic rat hearts. Diabetes Res Clin Pract. 1991;11:177-188.
8. Doursout M-F, Kashimoto S, Chelley JE. Cardiac function in the diabetic conscious rat. In: Negano M, Dhalla NS, eds. The Diabetic Heart. New York, NY: Raven Press Publishers; 1991:11-19.
9. Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science. 1986;232:1629-1632.
10. Miethke H, Wittig B, Nath H, Jungermann K. Gluconeogenic-glycolytic capacities and metabolic zonation in liver of rats with streptozotocin, non-ketotic as compared to alloxan, ketotic diabetes. Histochemistry. 1986;85:483-489.
11. Cameron NE, Cotter MA, Dines K, Love A. Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia. 1992;35:946-950.
12. Norton GR, Tsotetsi OJ, Woodiwiss AJ. Hydrochlorothiazide improves ventricular compliance and thus performance without reducing hypertrophy in renal artery stenosis in rats. Hypertension. 1993;21:638-645.
13. Trifunovic B, Norton GR, Duffield MJ, Avraam P, Woodiwiss AJ. An androgenic steroid decreases left ventricular compliance in rats. Am J Physiol. 1995;268:H1096-H1105.
14. Woodiwiss AJ, Norton GR. Exercise-induced cardiac hypertrophy is associated with an increased myocardial compliance. J Appl Physiol. 1995;78:1303-1311.
15. Mirsky I. Assessment of passive elastic stiffness of cardiac muscle: mathematical concepts, physiologic and clinical considerations, directions of future research. Prog Cardiovasc Dis. 1976;18:277-308.
16. Sagawa K, Maughan L, Suga J, Sunagawa K. Cardiac Contraction and the Pressure-Volume Relationship. New York, NY: Oxford University Press; 1988:58-70, 270-274.
17. Weber KT, Janicki J, Shroff SG, Pick R, Chen RM, Abrahams G, Bashey RI. Collagen remodelling of the pressure-overloaded hypertrophied non-human primate myocardium. Circ Res. 1988;62: 757-765.
18. Kobayashi K, Tarazi RC, Lavenberg W, Rakusan K. Coronary blood flow in genetic cardiac hypertension. Am J Cardiol. 1984;53: 1360-1364.
19. Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation. 1991;83:1771-1779.
20. Stegemann H, Stalder K. Determination of hydroxyproline. Clin Chim Acta. 1967;18:267-273.
21. Monnier VM, Kohn RR, Cerami A. Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci U S A. 1984;81:583-587.
22. Gilbert JC, Glantz SA. Determinants of left ventricular filling and of the diastolic pressure-volume relation. Circ Res. 1989;64:827-851.
23. Litwin SE, Raya TE, Anderson PG, Daugherty S, Goldman S. Abnormal cardiac function in the streptozotocin-diabetic rat. J Clin Invest. 1990;86:481-488.
24. Factor SM, Bhan R, Minase T, Wolinsky H, Sonnenblick EH. Hypertensive-diabetic cardiomyopathy in the rat. Am J Pathol. 1981;102:219-228.
25. Mall G, Mann J, Hasslacher C, Mattfeldt T, Ritz E, Onishi S. Morphometric study on the rat heart in combined renovascular hypertension and diabetes mellitus: evidence of early synergistic effects on myocytes. In: Negano M, Dhalla NS, eds. The Diabetic Heart. New York, NY: Raven Press Publishers; 1991:115-124.
26. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care. 1992;15:1835-1843.
27. Afzal N, Pierce GN, Elimban V, Beamish RE, Dhalla NS. Influence of verapamil on some subcellular defects in the diabetic cardiomyopathy. Am J Physiol. 1989;256:E453-E458.
28. Ganguly PK, Thliveris JA, Mehta A. Evidence against the involvement of nonenzymatic glycosylation in diabetic cardiomyopathy. Metabolism. 1990;39:769-773.